Distribution of single nucleotide polymorphisms between BCS patients and controls
| . | Cases . | Controls . | OR (95% CI) . |
|---|---|---|---|
| FXIII (Val34Leu) | |||
| GG, n (%) | 44 (46) | 40 (40) | 1* |
| GT, n (%) | 48 (50) | 53 (53) | 0.8 (0.5-1.5) |
| TT, n (%) | 4 (4) | 7 (7) | 0.5 (0.1-1.9) |
| T-allele frequency (%) | 29 | 34 | |
| PAI-1 (4G/5G) | |||
| 4G4G, n (%) | 19 (20) | 26 (27) | 1* |
| 4G5G, n (%) | 70 (74) | 62 (65) | 1.5 (0.8-3.1) |
| 5G5G, n (%) | 6 (6) | 7 (7) | 1.2 (0.3-4.1) |
| 5G-allele frequency (%) | 43 | 40 | |
| TAFI (1040) | |||
| CC, n (%) | 43 (44) | 46 (46) | 1* |
| CT, n (%) | 43 (44) | 41 (41) | 1.1 (0.6-2.0) |
| TT, n (%) | 11 (11) | 12 (12) | 1.0 (0.4-2.5) |
| T-allele frequency (%) | 34 | 33 | |
| TAFI (1583) | |||
| AA, n (%) | 51 (51) | 45 (45) | 1* |
| AT, n (%) | 34 (34) | 40 (40) | 0.8 (0.4-1.4) |
| TT, n (%) | 14 (14) | 16 (16) | 0.8 (0.4-1.8) |
| T-allele frequency (%) | 31 | 36 | |
| t-PA (−7351) | |||
| CC, n (%) | 48 (49) | 42 (42) | 1* |
| CT, n (%) | 41 (42) | 45 (45) | 0.8 (0.4-1.4) |
| TT, n (%) | 9 (9) | 13 (13) | 0.6 (0.2-1.6) |
| T-allele frequency (%) | 30 | 36 | |
| TPA (27739) | |||
| AA, n (%) | 77 (84) | 81 (84) | 1* |
| AG or GG, n (%) | 15 (16) | 16 (16) | 1.0 (0.5-2.1) |
| G-allele frequency (%) | 9 | 8 | |
| Fibrinogen (−148) | |||
| CC, n (%) | 49 (57) | 52 (54) | 1* |
| CT, n (%) | 29 (34) | 36 (38) | 0.9 (0.5-1.6) |
| TT, n (%) | 8 (9) | 8 (8) | 1.1 (0.4-3.0) |
| T-allele frequency (%) | 26 | 27 |
| . | Cases . | Controls . | OR (95% CI) . |
|---|---|---|---|
| FXIII (Val34Leu) | |||
| GG, n (%) | 44 (46) | 40 (40) | 1* |
| GT, n (%) | 48 (50) | 53 (53) | 0.8 (0.5-1.5) |
| TT, n (%) | 4 (4) | 7 (7) | 0.5 (0.1-1.9) |
| T-allele frequency (%) | 29 | 34 | |
| PAI-1 (4G/5G) | |||
| 4G4G, n (%) | 19 (20) | 26 (27) | 1* |
| 4G5G, n (%) | 70 (74) | 62 (65) | 1.5 (0.8-3.1) |
| 5G5G, n (%) | 6 (6) | 7 (7) | 1.2 (0.3-4.1) |
| 5G-allele frequency (%) | 43 | 40 | |
| TAFI (1040) | |||
| CC, n (%) | 43 (44) | 46 (46) | 1* |
| CT, n (%) | 43 (44) | 41 (41) | 1.1 (0.6-2.0) |
| TT, n (%) | 11 (11) | 12 (12) | 1.0 (0.4-2.5) |
| T-allele frequency (%) | 34 | 33 | |
| TAFI (1583) | |||
| AA, n (%) | 51 (51) | 45 (45) | 1* |
| AT, n (%) | 34 (34) | 40 (40) | 0.8 (0.4-1.4) |
| TT, n (%) | 14 (14) | 16 (16) | 0.8 (0.4-1.8) |
| T-allele frequency (%) | 31 | 36 | |
| t-PA (−7351) | |||
| CC, n (%) | 48 (49) | 42 (42) | 1* |
| CT, n (%) | 41 (42) | 45 (45) | 0.8 (0.4-1.4) |
| TT, n (%) | 9 (9) | 13 (13) | 0.6 (0.2-1.6) |
| T-allele frequency (%) | 30 | 36 | |
| TPA (27739) | |||
| AA, n (%) | 77 (84) | 81 (84) | 1* |
| AG or GG, n (%) | 15 (16) | 16 (16) | 1.0 (0.5-2.1) |
| G-allele frequency (%) | 9 | 8 | |
| Fibrinogen (−148) | |||
| CC, n (%) | 49 (57) | 52 (54) | 1* |
| CT, n (%) | 29 (34) | 36 (38) | 0.9 (0.5-1.6) |
| TT, n (%) | 8 (9) | 8 (8) | 1.1 (0.4-3.0) |
| T-allele frequency (%) | 26 | 27 |
Reference category.